Eva Ursula Hultqvist Bengtsson
Directeur Général chez Multihelix AB
Profil
Eva Ursula Hultqvist Bengtsson is the founder of Multihelix AB.
She currently holds positions as Chairman at Science Skills Ekonomisk Förening, Director at Medicon Valley Inhalation Consortium AB, and Assistant Professor at the University of Uppsala.
Her former positions include Chief Executive Officer at Medicon Village AB from 2012 to 2016, Chairman at Obducat AB from 2016 to 2017, Section Head-Clinical Research at Gambro AB, and Site Manager at AstraZeneca R & D Lund from 1995 to 2012.
Dr. Hultqvist Bengtsson received her undergraduate and doctorate degrees from the University of Lund.
Postes actifs de Eva Ursula Hultqvist Bengtsson
| Sociétés | Poste | Début |
|---|---|---|
Multihelix AB
 Multihelix AB Miscellaneous Commercial ServicesCommercial Services Multihelix AB is a Swedish consultancy company founded by Eva Ursula Hultqvist Bengtsson. The private company's mission is to create value for people's health and well-being by utilizing knowledge for sustainable growth. Eva Ursula Hultqvist Bengtsson has been the CEO since incorporation. | Directeur Général | - |
| University of Uppsala | Corporate Officer/Principal | - |
| Science Skills Ekonomisk Förening | Président | - |
| Medicon Valley Inhalation Consortium AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Eva Ursula Hultqvist Bengtsson
| Sociétés | Poste | Fin |
|---|---|---|
Medicon Village AB
 Medicon Village AB Miscellaneous Commercial ServicesCommercial Services Medicon Village AB operates as a life science center. The private company is located in Sweden. The CEO of the Swedish company is Kerstin Maria C. Åkesson Jakobsson. | Directeur Général | 01/01/2016 |
| AstraZeneca R & D Lund | Corporate Officer/Principal | 01/01/2012 |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - |
| OBDUCAT AB | Président | 01/01/2017 |
Formation de Eva Ursula Hultqvist Bengtsson
| University of Lund | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OBDUCAT AB | Electronic Technology |
| Entreprise privées | 6 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
Medicon Village AB
Medicon Village AB Miscellaneous Commercial ServicesCommercial Services Medicon Village AB operates as a life science center. The private company is located in Sweden. The CEO of the Swedish company is Kerstin Maria C. Åkesson Jakobsson. | Commercial Services |
Multihelix AB
Multihelix AB Miscellaneous Commercial ServicesCommercial Services Multihelix AB is a Swedish consultancy company founded by Eva Ursula Hultqvist Bengtsson. The private company's mission is to create value for people's health and well-being by utilizing knowledge for sustainable growth. Eva Ursula Hultqvist Bengtsson has been the CEO since incorporation. | Commercial Services |
| Science Skills Ekonomisk Förening | |
| Medicon Valley Inhalation Consortium AB | |
| AstraZeneca R & D Lund |